within Pharmacolibrary.Drugs.ATC.B;

model B03AB02
  extends Pharmacokinetic.Models.PK_2C(
    weight         = 70,
    F              = 1,
    Cl             = 5.166666666666667e-07,
    adminDuration  = 600,
    adminMass      = 40 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.0047,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,            
    Vdp             = 0.006900000000000001,
    k12             = 0.049,
    k21             = 0.049
    
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>B03AB02</td></tr><td>route:</td><td>intravenous</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Saccharated iron oxide is a colloidal iron preparation commonly used for intravenous iron supplementation in patients with iron deficiency anemia, especially when oral iron therapy is not tolerated or ineffective. It is used in clinical practice primarily in Japan and other Asian countries, and is approved for use there.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported in Japanese adult patients (n=24; 12 males and 12 females; age 20-38 years) after intravenous administration of 40 mg elemental iron as saccharated iron oxide.</p><h4>References</h4><ol><li><p>Okada, M, et al., &amp; Omae, T (1983). Hypophosphatemia induced by intravenous administration of Saccharated iron oxide. <i>Klinische Wochenschrift</i> 61(2) 99–102. DOI:<a href=\"https://doi.org/10.1007/BF01496662\">10.1007/BF01496662</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/6843038/\">https://pubmed.ncbi.nlm.nih.gov/6843038</a></p></li><li><p>Kaplinsky, C (2008). Parenteral iron therapy. <i>The Israel Medical Association journal : IMAJ</i> 10(5) 372–373. PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/18605363/\">https://pubmed.ncbi.nlm.nih.gov/18605363</a></p></li><li><p>Pai, AB (2017). Complexity of intravenous iron nanoparticle formulations: implications for bioequivalence evaluation. <i>Annals of the New York Academy of Sciences</i> 1407(1) 17–25. DOI:<a href=\"https://doi.org/10.1111/nyas.13461\">10.1111/nyas.13461</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/29027212/\">https://pubmed.ncbi.nlm.nih.gov/29027212</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end B03AB02;
